Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Codexis, Inc.
Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels.
IPO Date: April 22, 2010
Sector: Healthcare
Industry: Biotech
Market Cap: $232.79M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.23 | 2.79%
Avg Daily Range (30 D): $0.10 | 3.74%
Avg Daily Range (90 D): $0.09 | 3.81%
Institutional Daily Volume
Avg Daily Volume: .32M
Avg Daily Volume (30 D): .7M
Avg Daily Volume (90 D): .78M
Trade Size
Avg Trade Size (Sh.): 110
Avg Trade Size (Sh.) (30 D): 154
Avg Trade Size (Sh.) (90 D): 146
Institutional Trades
Total Inst.Trades: 1,245
Avg Inst. Trade: $1.46M
Avg Inst. Trade (30 D): $1.96M
Avg Inst. Trade (90 D): $2.61M
Avg Inst. Trade Volume: .12M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.29M
Avg Closing Trade (30 D): $1.39M
Avg Closing Trade (90 D): $1.09M
Avg Closing Volume: 90.63K
   
News
May 22, 2025 @ 11:00 AM
Codexis’ Landmark Presentations at TIDES US...
Source: N/A
Apr 9, 2025 @ 9:00 PM
Codexis Announces Byron Dorgan to Retire from Boar...
Source: N/A
Feb 20, 2025 @ 3:00 PM
Specialty Enzymes Market to Expand at 7.5% CAGR, R...
Source: Sns Insider
Dec 4, 2024 @ 6:00 PM
Global Artificial Sweeteners Market to Observe Gro...
Source: Delveinsight
Jul 1, 2024 @ 8:05 PM
Codexis Finalizes Purchase Agreement with Crosswal...
Source: Codexis, Inc.
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $-.25 $-.29
Diluted EPS $-.25 $-.29
Revenue $ $ 7.54M $ 12.83M
Gross Profit $ $ 4.81M $ 8.52M
Net Income / Loss $ $ -20.69M $ -20.64M
Operating Income / Loss $ $ -20.49M $ -16.56M
Cost of Revenue $ $ 2.73M $ 4.32M
Net Cash Flow $ $ -.94M $ 18.85M
PE Ratio